secwatch / observer
8-K filed April 15, 2026, 7:59 PM ET ticker IART CIK 0000917520
debt confidence high sentiment neutral materiality 0.50

Integra LifeSciences amends $150M A/R facility, extends termination to April 2029

INTEGRA LIFESCIENCES HOLDINGS CORP

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INTEGRA LIFESCIENCES HOLDINGS CORP entered into April 2026 Amendments with PNC Bank, National Association valued at amendment to $150 million accounts receivable securitization facility (effective 2026-04-10).

Action
entry
Agreement
credit facility
Counterparty
PNC Bank, National Association
Value
amendment to $150 million accounts receivable securitization facility
Effective
2026-04-10
Exact text from the filing
On April 10, 2026, (i) the Borrower and ILS Sales entered into Amendment No. 8 to Receivables Financing Agreement (the “RFA Amendment”), by and among the Borrower, ILS Sales, as Servicer, PNC, as Administrative Agent and Committed Lender, The Bank of Nova Scotia, as Committed Lender and Group Agent, PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time and (ii) the Borrower and ILS Sales entered into Amendment No. 1 to Purchase and Sale Agreement(the “PSA Amendment,” and together with the RFA Amendment, the “April 2026 Amendments”), by and between the Borrower, as Buyer and ILS Sales, as Servicer, and acknowledged and agreed by PNC, as Administrative Agent.
View on SEC.gov

85 material agreements filed in the last 30 days. Browse all material agreements →

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR
accession 0000917520-26-000019
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.